Semaglutide OXY-SEMA (5 mg) OxyPharma

Semaglutide is a GLP-1 receptor agonist, 94% identical in sequence to human GLP-1, that selectively binds and activates the GLP-1 receptor. It lowers blood glucose in a glucose-dependent manner by stimulating insulin secretion and reducing glucagon secretion, while also delaying gastric emptying and lowering appetite. This OxyPharma vial contains 5 mg of Semaglutide for reconstitution and subcutaneous use.

By combining glycemic control with a marked reduction in overall appetite, Semaglutide supports both blood sugar management and meaningful reductions in body weight and fat mass over time.

Key Benefits

• Selectively activates the GLP-1 receptor for glucose-dependent blood sugar control
• Reduces appetite, supporting steady reduction in body weight and fat mass
• Slows gastric emptying, extending feelings of fullness after meals
• Once-weekly dosing for simple, convenient administration
• Mid-size 5 mg vial suits users progressing past the initial titration phase